HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 210 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $355,000 | +14.5% | 20,000 | 0.0% | 0.01% | +8.3% |
| Q3 2019 | $310,000 | -9.9% | 20,000 | 0.0% | 0.01% | -7.7% |
| Q2 2019 | $344,000 | +6.8% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $322,000 | +9.9% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $293,000 | -90.5% | 20,000 | -88.2% | 0.01% | -87.0% |
| Q3 2018 | $3,089,000 | +7.7% | 170,000 | 0.0% | 0.10% | -6.5% |
| Q2 2018 | $2,868,000 | -13.9% | 170,000 | 0.0% | 0.11% | -23.0% |
| Q1 2018 | $3,330,000 | -3.3% | 170,000 | 0.0% | 0.14% | -5.4% |
| Q4 2017 | $3,444,000 | +16.6% | 170,000 | 0.0% | 0.15% | +15.7% |
| Q3 2017 | $2,953,000 | -75.7% | 170,000 | -82.1% | 0.13% | -74.3% |
| Q2 2017 | $12,176,000 | – | 949,800 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |